← Open Payments lookup

ZANE SAGHAIAN: Open Payments

NPI 1861039513 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$242 in 13 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $73 · 2025 $242

Food & beverage: $242
CompanyPaymentsAmount
Gilead Sciences, Inc.4$78
Lilly USA, LLC3$52
Phathom Pharmaceuticals, Inc.2$25
AstraZeneca Pharmaceuticals LP1$24
Alnylam Pharmaceuticals Inc.1$23
Dexcom, Inc.1$20
Boehringer Ingelheim Pharmaceuticals, Inc.1$19

Products named: MOUNJARO, VOQUEZNA, BREZTRI, GIVLAARI, Dexcom G6 Transmitter, JARDIANCE.

Industry payments across CA — which companies pay providers there.